Stonepine Capital Management, LLC has filed its 13F form on May 14, 2025 for Q1 2025 where it was disclosed a total value porftolio of $103 Billion distributed in 66 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Ani Pharmaceuticals Inc with a value of $13.6B, Evolus, Inc. with a value of $13.6B, Optinose Inc with a value of $7.23B, Kempharm, Inc with a value of $4.87B, and Verastem Inc with a value of $3.7B.

Examining the 13F form we can see an decrease of $21.1B in the current position value, from $124B to 103B.

Stonepine Capital Management, LLC is based out at Bend, OR

Below you can find more details about Stonepine Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $103 Billion
Healthcare: $76.3 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 66
  • Current Value $103 Billion
  • Prior Value $124 Billion
  • Filing
  • Period Q1 2025
  • Filing Date May 14, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 23 stocks
  • Additional Purchases 18 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 24 stocks
Track This Portfolio

Track Stonepine Capital Management, LLC Portfolio

Follow Stonepine Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonepine Capital Management, LLC with notifications on news.